Hinge Health (HNGE) Just Bought Its Way Into A New Market, So Now What?
On August 4, Hinge Health (NASDAQ:HNGE) delivered a quarter that beat its own guidance on nearly every line, then turned around and used the extra cash to buy its way into a brand new category. Revenue grew 53% year-over-year, margins expanded by roughly 1,000 basis points, and the company still found $105 million to acquire […]
Yahoo22 days agoHNGE
Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?
HNGE's rapid revenue growth, widening margins and higher 2026 outlook strengthen its case, but expansion raises execution risks.
Yahoo23 days agoHNGE
Hinge Health's Cylinder Deal Opens a $135B GI Care Growth Opportunity
HNGE's $105 million Cylinder deal opens a $135 billion GI care market, adding nearly 100 clients and about 2 million lives.
Yahoo23 days agoHNGE
HNGE Rallies 64.6% in 3 Months as Growth and Margins Gain Momentum
Hinge Health 64.6% three-month rally is backed by surging revenues, wider margins and a raised 2026 outlook, but execution expectations are rising.
Yahoo23 days agoHNGE
Is the Options Market Predicting a Spike in Hinge Health Stock?
Investors need to pay close attention to HNGE stock based on the movements in the options market lately.
Yahoo23 days agoHNGE
Omada Health: Q2 Shows More Evidence Of Growth Converting Into Earnings
Omada Health (OMDA) delivered strong Q2 results, with 43% revenue growth, margin expansion, and positive adj. EBITDA, reinforcing my buy rating.
SeekingAlpha23 days agoHNGE
Hinge Health (HNGE) Q2 2026 Earnings Call Transcript
Yield improvements and member engagement drove 53% revenue growth in the quarter.
Yahoo23 days agoHNGE